| Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program RB Shah, R Mehra, AM Chinnaiyan, R Shen, D Ghosh, M Zhou, ... Cancer research 64 (24), 9209-9216, 2004 | 728 | 2004 |
| TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion S Perner, JM Mosquera, F Demichelis, MD Hofer, PL Paris, J Simko, ... The American journal of surgical pathology 31 (6), 882-888, 2007 | 571 | 2007 |
| Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma N Palanisamy, B Ateeq, S Kalyana-Sundaram, D Pflueger, ... Nature medicine 16 (7), 793-798, 2010 | 550 | 2010 |
| Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications JM Mosquera, S Perner, EM Genega, M Sanda, MD Hofer, KD Mertz, ... Clinical Cancer Research 14 (11), 3380-3385, 2008 | 280 | 2008 |
| PTEN genomic deletion is associated with p‐Akt and AR signalling in poorer outcome, hormone refractory prostate cancer K Sircar, M Yoshimoto, FA Monzon, IH Koumakpayi, RL Katz, A Khanna, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2009 | 269 | 2009 |
| Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatmentrelated neuroendocrine prostate cancer JM Mosquera, H Beltran, K Park, TY MacDonald, BD Robinson, ... Neoplasia 15 (1), 1-IN4, 2013 | 267 | 2013 |
| Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis TLA Nguyên, H Abdelbary, M Arguello, C Breitbach, S Leveille, JS Diallo, ... Proceedings of the National Academy of Sciences 105 (39), 14981-14986, 2008 | 219 | 2008 |
| Identification of a novel truncating PALB2mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women WD Foulkes, P Ghadirian, MR Akbari, N Hamel, S Giroux, N Sabbaghian, ... Breast Cancer Research 9, 1-9, 2007 | 187 | 2007 |
| Morphological features of TMPRSS2–ERG gene fusion prostate cancer JM Mosquera, S Perner, F Demichelis, R Kim, MD Hofer, KD Mertz, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2007 | 186 | 2007 |
| Filamin A regulates focal adhesion disassembly and suppresses breast cancer cell migration and invasion Y Xu, TA Bismar, J Su, B Xu, G Kristiansen, Z Varga, L Teng, DE Ingber, ... Journal of Experimental Medicine 207 (11), 2421-2437, 2010 | 184 | 2010 |
| Decreased α-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific death MA Rubin, TA Bismar, O Andrén, L Mucci, R Kim, R Shen, D Ghosh, ... Cancer Epidemiology Biomarkers & Prevention 14 (6), 1424-1432, 2005 | 173 | 2005 |
| PTEN Deletion in Prostate Cancer Cells Does Not Associate with Loss of RAD51 Function: Implications for Radiotherapy and Chemotherapy M Fraser, H Zhao, KR Luoto, C Lundin, C Coackley, N Chan, AM Joshua, ... Clinical Cancer Research 18 (4), 1015-1027, 2012 | 158 | 2012 |
| Prognostic significance of CD8+ T lymphocytes in breast cancer depends upon both oestrogen receptor status and histological grade K Baker, J Lachapelle, I Zlobec, TA Bismar, L Terracciano, WD Foulkes Histopathology 58 (7), 1107-1116, 2011 | 151 | 2011 |
| A novel experimental heme oxygenase-1–targeted therapy for hormone-refractory prostate cancer MA Alaoui-Jamali, TA Bismar, A Gupta, WA Szarek, J Su, W Song, Y Xu, ... Cancer research 69 (20), 8017-8024, 2009 | 150 | 2009 |
| Multiple measures of carcinoma extent versus perineural invasion in prostate needle biopsy tissue in prediction of pathologic stage in a screening population TA Bismar, JS Lewis, RT Vollmer, PA Humphrey The American journal of surgical pathology 27 (4), 432-440, 2003 | 146 | 2003 |
| Renal oncocytoma revisited: a clinicopathological study of 109 cases with emphasis on problematic diagnostic features K Trpkov, A Yilmaz, D Uzer, KM Dishongh, CM Quick, TA Bismar, ... Histopathology 57 (6), 893-906, 2010 | 139 | 2010 |
| Prostate needle biopsy reporting: how are the surgical members of the Society of Urologic Oncology using pathology reports to guide treatment of prostate cancer patients? MA Rubin, TA Bismar, S Curtis, JE Montie The American journal of surgical pathology 28 (7), 946-952, 2004 | 133 | 2004 |
| PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancer TA Bismar, M Yoshimoto, RT Vollmer, Q Duan, M Firszt, J Corcos, ... BJU international 107 (3), 477-485, 2011 | 130 | 2011 |
| Fascin regulates prostate cancer cell invasion and is associated with metastasis and biochemical failure in prostate cancer AD Darnel, E Behmoaram, RT Vollmer, J Corcos, K Bijian, K Sircar, J Su, ... Clinical Cancer Research 15 (4), 1376-1383, 2009 | 129 | 2009 |
| Defining aggressive prostate cancer using a 12-gene model TA Bismar, F Demichelis, A Riva, R Kim, S Varambally, L He, J Kutok, ... Neoplasia 8 (1), 59-68, 2006 | 126 | 2006 |
